June 2026
1. SPARTZ A, Schmidt S, Mohamed F, Troness B, et al
   Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation.
   Clin Exp Metastasis. 2026;43:30.
   

   >> Share

   
   
2. PRICE ML, Zhou J, Le Maitre CL, Quayle LA, et al
   Mechanisms of breast cancer dormancy in bone metastasis.
   Clin Exp Metastasis. 2026;43:31.
   

   >> Share

   
   January 2026
3. RAVICHANDRAN A, Upton K, Taheri S, Liu C, et al
   Digital spatial profiling identifies features of primary and locoregional metastatic vasculature in triple negative breast cancer.
   Clin Exp Metastasis. 2026;43:11.
   

   >> Share

   
   
4. HANSSON E, Sunden M, Wadsten C, Rask G, et al
   Breast cancer liver metastases and the impact of receptor expression on survival.
   Clin Exp Metastasis. 2026;43:8.
   

   >> Share

   
   October 2025
5. BENDRICH S, Pietrkiewicz MAW, Schirmer MA, Ammon HE, et al
   Borderline decisions in brain-metastatic breast cancer: efficacy of multimodality treatments in breast cancer patients with very limited prognosis suffering from brain metastases.
   Clin Exp Metastasis. 2025;42:62.
   

   >> Share

   
   
6. CORONADO-ALVARADO CD, Astiazaran-Garcia H
   Defining the Tumor-Bone axis: the role of extracellular vesicles in a crucial exchange route for breast cancer development and progression.
   Clin Exp Metastasis. 2025;42:59.
   

   >> Share

   
   September 2025
7. NATHANSON SD, Dieterich LC, Zhang XH, Chitale DA, et al
   Correction: Associations amongst genes, molecules, cells, and organs in breast cancer metastasis.
   Clin Exp Metastasis. 2025;42:55.
   

   >> Share

   
   August 2025
8. ZHANG W, Rahman S, Wu AML, Isanogle K, et al
   A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models.
   Clin Exp Metastasis. 2025;42:45.
   

   >> Share

   
   July 2025
9. BINDEMAN WE, Corn KC, Rafat M, Fingleton B, et al
   Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-kappaB signaling.
   Clin Exp Metastasis. 2025;42:40.
   

   >> Share

   
   May 2025
10. RUSSANO F, Corrado G, Bonadies A, Migliano E, et al
    Prospective multicentre study of patients with cutaneous metastases from breast cancer treated with electrochemotherapy.
    Clin Exp Metastasis. 2025;42:32.
    

    >> Share

    
    April 2025
11. ROQUET N, Beddok A, Loo M, Calais G, et al
    Post-operative hypofractionated stereotactic radiotherapy for brain metastases from lung and breast cancer in patients without prior WBRT: a retrospective dose escalation study.
    Clin Exp Metastasis. 2025;42:27.
    

    >> Share

    
    
12. CHEN L, Chow A, Ma W, Coker C, et al
    A new, immunocompetent brain-metastatic mouse model of HER2-positive breast cancer.
    Clin Exp Metastasis. 2025;42:25.
    

    >> Share

    
    
13. LIANG H, Yin G, Feng D, Shi G, et al
    Ras-proximate-1 (RAP1): a prognosis and therapeutic target in the metastatic spread of breast cancer.
    Clin Exp Metastasis. 2025;42:23.
    

    >> Share

    
    December 2024
14. FABIAN A, Buergy D, Weykamp F, Horner-Rieber J, et al
    Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study.
    Clin Exp Metastasis. 2024;42:6.
    

    >> Share

    
    September 2024
15. MERLONI F, Palleschi M, Gianni C, Sirico M, et al
    Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives.
    Clin Exp Metastasis. 2024 Sep 23. doi: 10.1007/s10585-024-10312.
    

    >> Share

    
    
16. ZHENG Q, Zhou T, Ding W
    Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis.
    Clin Exp Metastasis. 2024 Sep 4. doi: 10.1007/s10585-024-10307.
    

    >> Share

    
    June 2024
17. CHEN K, Dong Y, He G, He X, et al
    UBTF mediates activation of L3MBTL2 to suppress NISCH expression through histone H2AK119 monoubiquitination modification in breast cancer.
    Clin Exp Metastasis. 2024 Jun 27. doi: 10.1007/s10585-024-10299.
    

    >> Share

    
    
18. GRUBE M, Dimmler A, Schmaus A, Saup R, et al
    Ketogenic diet does not promote triple-negative and luminal mammary tumor growth and metastasis in experimental mice.
    Clin Exp Metastasis. 2024;41:251-266.
    

    >> Share

    
    May 2024
19. BAUGH AG, Gonzalez E, Narumi VH, Kreger J, et al
    A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer.
    Clin Exp Metastasis. 2024 May 8. doi: 10.1007/s10585-024-10289.
    

    >> Share

    
    April 2024
20. BHAT V, Piaseczny M, Goodale D, Patel U, et al
    Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis.
    Clin Exp Metastasis. 2024 Apr 6. doi: 10.1007/s10585-024-10284.
    

    >> Share

    
    March 2024
21. LEDUC S, Nguyen HL, Richard F, Zels G, et al
    Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases.
    Clin Exp Metastasis. 2024 Mar 29. doi: 10.1007/s10585-024-10279.
    

    >> Share

    
    
22. LIBRING S, Berestesky ED, Reinhart-King CA
    The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria.
    Clin Exp Metastasis. 2024 Mar 15. doi: 10.1007/s10585-024-10269.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share